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SPLENIC ARTERY ANEURYSMS OCCURRING IN LIVER TRANSPLANT RECIPIENTS' 
Splenic artery aneurysms (SAA)* are found in 0.1% of the 
cases in large autopsy series (1) and in 0.8% of un selected 
abdominal aortograms (2). The incidence of SAA is higher in 
patients with portal hypertension, in whom it is reported to 
occur in 8.8% to 50% of cases (3, 4). Rupture of SAA carries a 
high mortality rate. 
Rupture of SAA in liver transplant recipients has been re-
ported (4,5). To assess the importance of this complication in 
the liver transplant population, we reviewed the medical records 
of all liver recipients whose 1311 transplants were performed 
at the Presbyterian University Hospital from January 1, 1988 
until July 1, 1990. Of 5 patients with ruptured SAA, 4 died. An 
additional patient was recognized to have a SAA following his 
second orthotopic liver transplantation and this was removed 
electively by splenectomy and distal pancreatectomy. Summar-
ies of these 6 cases are in Table 1. 
SAAs are the most common visceral arterial aneurysms and 
account for 60% of all aneurysms found within the splanchnic 
arterial bed (2). The pathogenesis of SAA is multifactorial, and 
Stanley et al. (2) have recognized 4 conditions that place 
patients at high risk: (1) arterial dysplasia, (2) portal hyperten-
sion, (3) focal arterial inflammatory processes, and (4) multi-
parity in women. Anatomically, about 70% of the SAAs in 
patients with cirrhosis and portal hypertension are located in 
the distal third of the artery, and half of the aneurysms are 
multiple (2, 3). In our series, 4 of the 5 liver transplant patients 
had aneurysms greater than 2 cm in diameter, and one had 
multiple aneurysms. 
Multiple factors could contribute to the higher incidence and 
larger size of SAAs in patients with chronic liver disease and 
portal hypertension. These include: increased splenic and over-
all splanchnic blood flow secondary to arteriovenous shunts 
and collateral formation; dilatation and elongation of the 
splenic artery (6, 7); increased cardiac output and splanchnic 
vasodilatation from hyperglucagonemia (8); and vascular 
changes caused by other hormone changes, such as those which 
"feminize" male cirrhotic patients (9). 
Whatever the explanation, the impact of SAA in liver trans-
plantation needs emphasis. In a recent study at the Mayo Clinic 
(4),60 patients with portal hypertension who were being con-
sidered for OLT were submitted to routine preoperative celiac 
angiography, and 5 (8.3%) were found to have SAA 8 to 25 mm 
in diameter. A sixth patient in this series developed a SAA 3 
months postoperatively. The size at which an asymptomatic 
SAA should arouse alarm has been reported to be 15 mm (4, 
5). There have been no reported ruptures of smaller SAAs in 
liver transplant recipients. Whatever the size, most SAAs are 
asymptomatic, as in 4 of our 5 patients. Pain in the mid upper 
1 This work was supported by research grants from the Veterans 
Administration and by project grant No. DK 29961 from the National 
Institutes of Health, Bethesda, Maryland. 
* Abbreviation: SAA, splenic artery aneurysm. 
or left upper quadrant of the abdomen is an ominous portent 
of imminent or contained rupture (2, 10, 11). 
The question of critical size of SAA in liver transplant 
candidates or recipients should be left open until there is more 
information. The incidence of rupture of documented SAA in 
nontransplant patients is 3% to 10% (2), but extra risk factors 
in liver recipients could include the higher rupture rate follow-
ing any intraabdominal operation (12), abrupt changes in celiac 
trunk blood flow caused by OLT (6, 7), the addition of post-
operative corticosteroids, inadvertent trauma to the aneurysm 
intraoperatively, opening of the retroperitoneal space, and the 
coagulopathy that often is a feature of perioperative recovery. 
Only one previously reported patient has survived a post-
transplant SAA rupture (4), and in our series, the mortality 
rate following rupture was 80%. Improvement will require 
identification of the pathology during pretransplantation 
workup. MRI is the most discriminating procedure, and we 
recommend it routinely. Doppler ultrasound of the splenic 
artery is less discriminating, and angiography is too dangerous 
in many patients with end-stage liver disease. With MRI, other 
essential information about liver size, portal vein patency, and 
the structure and flow patterns of the visceral arterial supply 
are obtained at the same time (13). 
Operative management should include ligation of the splenic 
artery distal and proximal to the aneurysm and resection if 
feasible (5). Proximal splenic artery ligation alone is apt to be 
ineffective because of rich collateral arterial supply. A delayed 
operation may be indicated if multiple or large distal SAAs are 
found that can not be ligated without splenectomy at the time 
of orthotopic liver transplantation. Although there may be a 
role for splenic artery embolization before or after transplan-
tation, we have not had personal experience. Splenic infarction 
and the formation of a splenic abscess is a potential complica-
tion of either splenic artery ligation without splenectomy or of 
embolization. 
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OLTx Age 
No. (yrs) 
1921 32 
1725 43 
1897 37 
1552 37 
1352 22 
1568 36 
Sex 
F 
F 
M 
F 
M 
F 
Diagnosis" 
HVC hepatitis 
Autoimmune 
hepatitis 
Sclerosing 
cholangitis 
HBV hepatitis 
HVC hepatitis 
Sclerosing 
cholangitis 
f ,. r t 
.b ~ \ 
~oAkpmiAkqAqflk 
Time of 
rupture 
postOLTx 
45 days 
49 days 
56 days 
10 days 
6 days 
TABLE 1. Summary 
Outcome 
Died 
Died 
Died 
Died 
Alive 
Alive 
LFT's at time of 
presentation 
SGOT 
SGPT 
PHOS 
GGT 
Bili 
SGOT 
SGPT 
PHOS 
Bili 
SGOT 
SGPT 
PHOS 
GGT 
Bili 
SGOT 
SGPT 
GGT 
PHOS 
Bili 
SGOT 
SGPT 
PHOS 
GGT 
Bili 
SGOT 
SGPT 
PHOS 
GGT 
Bili 
104 lUlL 
62 lUlL 
156 lUlL 
103 lUlL 
11.2 mg% 
157 lUlL 
151 lUlL 
210 lUlL 
1.3 mg% 
18 lUlL 
23 lUlL 
80 lUlL 
76 lUlL 
10mg% 
23 lUlL 
33 lUlL 
37 lUlL 
46 lUlL 
0.9mg% 
31 lUlL 
4 lUlL 
147 lUlL 
57 lUlL 
2.1 mg% 
67 lUlL 
416 lUlL 
187 lUlL 
190 lUlL 
5.9 mg% 
Pathology 
3-cm solitary 
SAAwith 
necrotic 
wall 
3-cm solitary 
SAA, 
splenic ar-
tery tor-
tuous and 
thin-
walled 
No size of 
aneurysm 
reported 
2-cm SAA 
with arte-
rial scle-
rosis and 
perfora-
tion 
Tortuous ar-
tery with 
multiple 
aneu-
rysms, 
largest 2 
cm 
No size of 
aneurysm 
reported 
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Comments 
(1) Elective splenectomy 8 
years pre-OL T 
(2) Splenic artery ligated as 
treatment for rupture 
(3) Second OLT postopera-
tive day 50 
(4) Died postoperative day 
124 
(1) Sudden death in hospital 
(2) Autopsy showed rejec-
tion of liver 
(1) First OLT primary graft 
dysfunction 
(2) Retransplanted on post-
operative day 3 
(3) Explored for bleeding on 
postoperative day 4 
(4) Died suddenly at home 
on postoperative day 56 
(1) Collapsed in the hospital 
(2) Died of irreversible shock 
24 hr after splenectomy 
(1) FirstOLTlost 14 months 
postoperative to recur-
rent HVC hepatitis 
(2) Following second OLT 
complained of persistent 
left upper quadrant pain 
(3) Angiography revealed le-
sion 
(4) Treated with splenec-
tomy and distal pancrea-
tectomy 
(1) Collapsed in the hospital 
(2) Underwent emergency 
splenectomy 
(3) Alive and well 
"All had chronic liver disease and cirrhosis. HVC, C hepatitis; HBV, B hepatitis; PNC, postnecrotic cirrhosis; OLT, orthotopic liver 
transplantation. 
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ISOLATED SPLENIC VEIN THROMBOSIS AS A CAUSE OF MASSIVE UPPER-GASTROINTESTINAL 
BLEEDING FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION 
Vascular and biliary complications (1-4) are among the 
major postoperative complications associated with orthotopic 
liver transplantation. These are more common in the pediatric 
age group, particularly because of technical difficulties associ-
ated with anastomosing smaller conduits (5). Although not 
always fatal, vascular complications, such as thrombosis or 
stenosis of the hepatic artery or portal vein, can cause severe 
morbidity (1, 4, 6), or necessitate retransplantation (7, 8). A 
leak from the biliary anastomosis, while sometimes secondary 
to an hepatic artery complication (4), can also complicate the 
postoperative course, leading to infections and/or other local 
problems (1). 
Massive variceal bleeding following OL T has been reported 
to occur secondary to portal vein thrombosis (6, 9-11). Other 
reported causes of severe UGI bleeding include cytomegalovirus 
gastroenteritis, peptic ulcer disease, and bleeding from the 
choledochojejunostomy anastomosis (1). We report massive 
variceal bleeding following OL T that occurred secondary to 
isolated splenic vein thrombosis and resultant left-sided portal 
hypertension. This was preceded by a biliary anastomotic leak 
that was managed with percutaneous drainage. The patient 
required operative gastrotomy for oversewing of bleeding gas-
tric varices and splenectomy. 
A 14-year-old girl was admitted to the pediatric intensive 
care unit with fulminant hepatic failure secondary to newly 
diagnosed Wilson's disease. She developed acute renal failure 
secondary to hemolysis, and postdilutional hemofiltration was 
initiated. On the fifth hospital day she was encephalopathic 
(stage IV), required mechanical ventilation for respiratory fail-
ure, and epinephrine and norepinephrine for blood pressure 
support, when a donor liver became available. The donor (age 
58) liver had no gross vascular anomalies, and the OL Twas 
performed in the standard fashion: i.e., end-to-end suprahepatic 
and infrahepatic inferior vena cava (IVC)* and portal vein (PV) 
anastomoses, and anastomosis of the donor celiac trunk to the 
recipient hepatic artery at the trumpeted common hepatic 
artery (CHA) bifurcation. The biliary conduit was recon-
structed using an end-to-end choledochocholedochostomy with 
aT-tube stent. Venovenous bypass was not used (12). 
During the operation, she underwent continuous hemofiltra-
tion via femoral arterial and venous lines. At the end of the 
operation, external cardiac compression was necessary. Positive 
and expiratory pressure (PEEP) of greater than 45 was required 
for sufficient ventilation. 
During the first week postoperatively, her renal function 
improved although liver function remained poor. She demon-
strated massive fluid requirements, and her weight increased 
from 60 kg to greater than 100 kg. Her abdominal girth nearly 
doubled, without evidence of bleeding. This caused increased 
tension on the T-tube and was the probable cause of the biliary 
anastomotic disruption that was identified by T -tube cholan-
giogram. By Doppler/ultrasound (US), the PV, CHA, and IVC 
were all patent. Bile extravasation was mostly medial and in 
the lesser sac area. This was managed non operatively with a 
percutaneous transhepatic biliary stent. A separate drain was 
* Abbreviations: CHA, common hepatic artery; CV, coronary vein; 
lVC, inferior vena cava; PEEP, positive end expiratory pressure; PV, 
portal vein; SV, splenic vein; US, ultrasound. 
placed in the collection. Candida albicans and enterococcus were 
recovered from this collection and simultaneously obtained 
blood cultures. The patient was placed on appropriate antibiotic 
therapy, and the left side of the incision was opened due to 
Candida wound sepsis. This wound later dehisced. There was 
no evidence of pancreatitis by changes in serum amylase or 
abdominal CT scan. The patient continued to have persistent 
fevers and cholangitis for 2 weeks and required reaspiration of 
a second lesser sac collection. Repeat cholangiograms showed 
improvement, and gradually she began to recover. Her liver 
function showed slow but steady improvement. One month 
after the first biliary drainage procedure, she experienced UGI 
hemorrhage requiring transfusion of 3 units of packed RBCs. 
UGI endoscopy revealed a bleeding ulcer on the lesser curve of 
the stomach, which was cauterized. There was no evidence of 
esophageal or gastric varices, erosive gastritis, or peptic ulcer 
disease. At the same time a Doppler/US examination again 
showed patent vessels and hepatopetal portal flow. Her liver 
function remained stable, and there was no change in her 
coagulation profile, which was normal. One week later she had 
an episode of massive UGI bleeding that was not controllable 
with endoscopy. Doppler/US examination again did not reveal 
any abnormality in the vessels in the portahepatis. Celiac, 
splenic and superior mesenteric arteriograms did not show an 
arterial source. However, in the venous phase, thrombosis of 
the splenic vein in the segment proximal to the portal vein 
confluence (central splenic vein thrombosis), and numerous 
gastric varices were demonstrated. The main portal vein was 
patent. The patient then underwent gastrotomy with suture 
ligation of bleeding gastric varices and splenectomy. Postoper-
atively, she developed a pseudocyst in the pancreatic tail that 
resolved following percutaneous drainage. Subsequently, the 
patient recovered with steadily improving liver function and 
was discharged home approximately 4 months following trans-
plantation. She continues to do well more than one year after 
the transplant and is back in school. 
UGI bleeding occurring after OLT has been reported follow-
ing portal vein thrombosis, CMV gastroenteritis, stress or 
steroid-related gastritis, peptic ulcer disease, and in association 
with the choledochojejunostomy anastomosis (1, 6). PV ste-
nosis or thrombosis usually results in deterioration of liver 
function, as well as portal hypertension that can lead to variceal 
bleeding (6). PV thrombosis or stenosis after OLT often re-
quires revascularization (9-11) or retransplantation (7,8). In 
the case presented, PV flow and liver function remained unaf-
fected during the bleeding episodes. The source of bleeding was 
initially thought to be arterial because of endoscopic findings 
and the persistence of the Doppler-demonstrated patent portal 
vein. Arteriography was performed in order to embolize a 
potential arterial source, but instead it demonstrated, in the 
venous phase, a distinctly different lesion. 
Splenic vein (SV) thrombosis (in the non-OL T setting) has 
been reported most commonly in association with the inflam-
matory processes of acute or chronic pancreatitis or pancreatic 
cancer (13-17). Other etiologies have included sclerotherapy, 
trauma, erosion of benign gastric ulcers, lymphoma, retroperi-
toneal fibrosis, and myeloproliferative disorders (16, 18, 19). 
Patients with these conditions usually present with splenomeg-
aly and UGI bleeding, although some are asymptomatic. Liver 
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FIGURE 1. Upper panel demonstrates normal portosplenic venous 
anatomy. Lower panel demonstrates central splenic vein thrombosis in 
this patient. Venous flow from the spleen is through the short gastric 
vessels (SGV), gastroepiploic vein (GEV), and the inferior mesenteric 
vein (lMV). The portal vein (PV) is patent. The coronary vein (CV) 
was not visualized. 
function is normal, and, as in our case, esophageal and gastric 
varices are not usually seen, although thickened gastric folds 
may be noted on endoscopy (15, 16). The diagnosis is best 
made radiographically (15, 16,20). Doppler/US of OLT recip-
ients is useful as a screen (21), although arteriography, and 
particularly the venous phase, unequivocally establishes the 
diagnosis of splenic vein thrombosis (3,22). Depending on the 
drainage of the coronary vein, there mayor may not be esoph-
ageal varices in addition to the gastric varices. If the coronary 
vein (CV) drains into the portal vein (24%) then the esophageal 
veins can be decompressed. If the CV drains into the SV (17%), 
the esophageal veins will not be decompressed and can develop 
into varices. In 59% of cases, the CV drains into the confluence 
of the PV /SV, and decompression of the esophageal vein then 
depends on the extent of the SV thrombosis (15). In our case, 
gastric varices were noted on venous phase angiography, the 
PV was patent, the CV was not seen, and the central aspect of 
the splenic vein was thrombosed (Fig. 1). 
In this case, the biliary anastomotic breakdown resulted in 
an abscess in the lesser sac, contiguous with the pancreas. 
Although there was no evidence of pancreatitis by serial amy-
lase determinations or CT scan of the abdomen, it is possible 
that inflammation in this area resulted in SV thrombosis (15). 
Similarly, electrocautery of the bleeding site on the lesser curve 
of the stomach may have predisposed to SV thrombosis by 
virtue of proximity. However, only one week later considerable 
gastric varices were apparent by angiography, and this time 
course is probably too rapid. There is one description of hepatic 
artery thrombosis due to acute pancreatitis after OLT, but 
there is no mention of SV thrombosis or UGI bleeding (23). 
Furthermore, reports of bile duct leaks (1, 2, 24-27), or pan-
creatitis (24, 28), following OLT have not described SV throm-
bosis or gastric variceal bleeding as complications. There is 
some evidence that a coagulopathy occurring with a high inci-
dence in children following OLT, due to a deficiency of protein 
C, predisposes to a high rate of PV thrombosis (29). However, 
protein C levels were noted to be normal in this patient. 
In this case, as well as in the non-OLT setting, splenectomy 
is curative for gastric variceal bleeding secondary to SV throm-
bosis (15, 16). Gastrotomy and oversewing of varices are ad-
vised if there is active bleeding at the time of surgery (15). The 
splenectomy can be technically challenging with significant 
blood loss (15). 
In the setting of OLT, where bile leaks are not uncommon, 
and many factors influence liver function and coagulation, the 
development of massive variceal bleeding should prompt angio-
graphic study to differentiate PV from SV thrombosis. Isolated 
SV thrombosis, as in our case, can be treated with splenectomy, 
with or without gastrotomy, and oversewing of bleeding vessels, 
while PV thrombosis, requires significantly different therapy 
(6). 
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